Live
- Thrissur Pooram 2024: A Celebration of Tradition and Spirituality
- Akshaya Tritiya 2024: Date and Significance
- Kamada Ekadashi 2024: Date, Auspicious Timings And Significance
- Aamir Khan’s son Junaid wraps up filming for his second movie
- Vijay Sethupathi’s heartwarming gesture wins netizens’ hearts
- Excitement builds as Nabha Natesh and Priyadarshi paired up
- Gurinder Chadha all set to make a comeback to big screen
- Palle Sindhura Reddy flays YS Jagan during election campaign in Puttaparthi
- KK Raju files nomination amid public celebrations and predicts victory with 45k vote majority
- Vijayawada Central Candidate Vellampally Srinivas Campaigns in 28th Division Railway Colony
Aurobindo Pharma to buy specific biz assets of US firm
Aurobindo Pharma on Thursday said its subsidiary Auro Vaccines LLC has entered into a pact to acquire certain business assets from Profectus BioSciences Inc USA for an upfront cash consideration of $11.29 million (around Rs 80 crore) with potential earn-outs on achieving certain milestones.
Hyderabad: Aurobindo Pharma on Thursday said its subsidiary Auro Vaccines LLC has entered into a pact to acquire certain business assets from Profectus BioSciences Inc USA for an upfront cash consideration of $11.29 million (around Rs 80 crore) with potential earn-outs on achieving certain milestones.
Auro Vaccines LLC is a wholly-owned subsidiary of Aurobindo Pharma USA Inc, USA, which is a wholly-owned arm of the company.
The indicative time period for completion of acquisition of research and development assets of Profectus BioSciences Inc is first half of 2020, it added.
The acquisition provides access to proprietary and innovative technology platforms for prophylactic use and therapeutic use along with global R&D center, Aurobindo Pharma said.
